Public Employees Retirement System Of Ohio Chimerix Inc Transaction History

Public Employees Retirement System Of Ohio

$25.2 Billion
Q2 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 19, 2023	BUY	$1.1 - $1.54 $6,052 - $8,473	5,502 Added 13.19%	47,221 $57,000
Q2 2023 Aug 15, 2023	BUY	$1.1 - $1.54 $6,052 - $8,473	5,502 Added 13.19%	47,221 $57,000
Q1 2023 Dec 19, 2023	SELL	$1.19 - $2.09 $54,185 - $95,166	-45,534 Reduced 52.19%	41,719 $52,000
Q1 2023 May 15, 2023	SELL	$1.19 - $2.09 $54,185 - $95,166	-45,534 Reduced 52.19%	41,719 $53,000
Q4 2022 Dec 19, 2023	BUY	$1.67 - $2.35 $145,712 - $205,044	87,253 New	87,253 $162,000
Q4 2022 Feb 15, 2023	BUY	$1.67 - $2.35 $91,437 - $128,669	54,753 Added 168.47%	87,253 $162,000
Q3 2022 Nov 15, 2022	BUY	$1.81 - $2.76 $58,825 - $89,700	32,500 New	32,500 $63,000
Q1 2021 May 14, 2021	SELL	$4.76 - $11.25 $274,099 - $647,820	-57,584 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.43 - $5.42 $19,887 - $44,357	-8,184 Reduced 12.44%	57,584 $278,000
Q2 2020 Aug 17, 2020	BUY	$1.33 - $3.63 $87,471 - $238,737	65,768 New	65,768 $204,000
Q1 2020 May 13, 2020	SELL	$1.27 - $2.33 $60,960 - $111,840	-48,000 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$1.93 - $4.21 $92,640 - $202,080	48,000 New	48,000 $113,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account